Identification of some interleukin-1 (IL-1) sensitive organs in vivo using the induction of ornithine decarboxylase (ODC) following injection of recombinant IL-1 beta in mice.
Intraperitoneal (i.p.) and intravenous (i.v.) injection of human recombinant interleukin-1 beta (rIL-1 beta) in mice produced a 2-4 fold induction of ornithine decarboxylase (ODC) in liver and heart six hours after administration. Lymphoid organs (thymus and spleen) and brain did not respond to rIL-1 beta administration with significant increases in ODC. IL-1-induced responses in heart seemed not to be secondary to stress induced catecholamine release since the beta-adrenergic antagonist propranolol did not inhibit the induction of ODC produced by injection rIL-1 beta. Injection of 10 micrograms bacterial lipopolysaccharide (LPS), an inducer of IL-1 synthesis, exhibited a pattern of tissue responsiveness which was distinct from the responses elicited by rIL-1 beta, most notably a marked 5-fold induction of ODC in spleen. The differences in the responses of various organs to rIL-1 beta vs. LPS suggested that the in vivo effects of LPS may involve more than stimulation of the release of IL-1. The identification of heart as an IL-1 sensitive tissue merits further study to define the contribution of IL-1 to cardiac physiology and pathophysiology.